SCHEMBL2893106

SCHEMBL2893106

CCCCC(Br)C=CC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.53
BACE1 P56817 1/20 0.53
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
CA2 P00918 2/20 0.41
MAPK1 P28482 1/20 0.41
HCAR2 Q8TDS4 3/20 0.40
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2893103 1.00 ACHE (0.53) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL11213136 0.88 ACHE (0.43) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL11213133 0.88 ACHE (0.43) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL18300758 0.79 ZDHHC7 (0.43) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL18300757 0.79 ZDHHC7 (0.43) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL263011 0.79
SCHEMBL4314107 0.79
SCHEMBL11277225 0.78 DNM1 (0.39) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL11277223 0.78 DNM1 (0.39) ACHEBACE1LCKPPARDZDHHC20
SCHEMBL8828842 0.78 ACHE (0.76) ACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286073-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE GENERICS (UK) LIMITED (GB) 2010-11-11 US claimed
EP-2205229-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE Mintails Limited (CY) 2010-07-14 EP claimed
WO-2009044202-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE MINTAILS LIMITED (CY) 2009-04-09 WO claimed
EP-1469816-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2004-10-27 EP claimed
US-20040198821-A1 Reduction of hair growth GILLETTE COMPANY, THE 2004-10-07 US claimed
US-20040131568-A1 Topical applying a fatty acid metabolism inhibitor; adriamycin, mercaptopropionic acid GILLETTE COMPANY, THE 2004-07-08 US claimed
US-20030202950-A1 Reduction of hair growth THE GILLETTE COMPANY 2003-10-30 US claimed
US-20030153619-A1 Applying on the skin, inhibiting fatty acid metabolism, using adriamycin, or enzyme inhibitors, dermatology GILLETTE COMPANY, THE 2003-08-14 US claimed
WO-2003063810-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2003-08-07 WO claimed
US-20100286073-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE GENERICS (UK) LIMITED (GB) 2010-11-11 US disclosed
EP-2205229-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE Mintails Limited (CY) 2010-07-14 EP disclosed
WO-2009044202-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE MINTAILS LIMITED (CY) 2009-04-09 WO disclosed
US-7160921-B2 Reduction of hair growth THE GILLETTE COMPANY (US) 2007-01-09 US disclosed
EP-1469816-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2004-10-27 EP disclosed
US-20040198821-A1 Reduction of hair growth GILLETTE COMPANY, THE 2004-10-07 US disclosed
US-20040131568-A1 Topical applying a fatty acid metabolism inhibitor; adriamycin, mercaptopropionic acid GILLETTE COMPANY, THE 2004-07-08 US disclosed
US-20030202950-A1 Reduction of hair growth THE GILLETTE COMPANY 2003-10-30 US disclosed
US-20030153619-A1 Applying on the skin, inhibiting fatty acid metabolism, using adriamycin, or enzyme inhibitors, dermatology GILLETTE COMPANY, THE 2003-08-14 US disclosed
WO-2003063810-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2003-08-07 WO disclosed